TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 81 filers reported holding TRINITY BIOTECH PLC in Q4 2015. The put-call ratio across all filers is 79.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 300 | +100.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -94.6% | 150 | -95.3% | 0.00% | -100.0% |
| Q4 2015 | $37,000 | -14.0% | 3,202 | -11.8% | 0.00% | 0.0% |
| Q3 2015 | $43,000 | +290.9% | 3,632 | +500.3% | 0.00% | – |
| Q2 2015 | $11,000 | -8.3% | 605 | -5.6% | 0.00% | – |
| Q1 2015 | $12,000 | -14.3% | 641 | -20.4% | 0.00% | – |
| Q4 2014 | $14,000 | -84.1% | 805 | -83.2% | 0.00% | -100.0% |
| Q3 2014 | $88,000 | -22.1% | 4,805 | -1.7% | 0.00% | -33.3% |
| Q2 2014 | $113,000 | -15.0% | 4,890 | -11.2% | 0.00% | -25.0% |
| Q1 2014 | $133,000 | -4.3% | 5,504 | -0.5% | 0.00% | 0.0% |
| Q4 2013 | $139,000 | +18.8% | 5,531 | +3.3% | 0.00% | 0.0% |
| Q3 2013 | $117,000 | +41.0% | 5,354 | +9.2% | 0.00% | +33.3% |
| Q2 2013 | $83,000 | – | 4,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 672,100 | $14,625,000 | 5.62% |
| GOLDMAN CAPITAL MANAGEMENT INC | 312,000 | $6,789,000 | 4.48% |
| Lyon Street Capital, LLC | 407,586 | $8,870,047,000 | 4.37% |
| GREAT POINT PARTNERS LLC | 189,071 | $4,114,000 | 2.85% |
| Adirondack Research & Management Inc. | 161,507 | $3,514,000 | 2.02% |
| Park West Asset Management LLC | 483,355 | $10,518,000 | 1.56% |
| Benchmark Capital Advisors | 56,954 | $1,239,000 | 0.89% |
| WOODMONT INVESTMENT COUNSEL LLC | 76,607 | $1,667,000 | 0.61% |
| SHEPHERD KAPLAN KROCHUK, LLC | 156,000 | $3,394,000 | 0.55% |
| HEARTLAND ADVISORS INC | 1,250,364 | $27,208,000 | 0.50% |